Psychopharmacological issues in the treatment of TBI and PTSD

Clinical Neuropsychologist

Volumn 23, Issue 8, 2009, Pages 1338-1367

  McAllister, Thomas W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Pharmacological treatment; PTSD; TBI

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CLONIDINE; CYCLOSERINE; DONEPEZIL; GUANFACINE; LAMOTRIGINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PINDOLOL; PLACEBO; PROPRANOLOL; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAGABINE; TOPIRAMATE; VENLAFAXINE;

AMNESIA; ANXIETY DISORDER; AROUSAL; BAROTRAUMA; BRAIN; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; HUMAN; MENTAL DISEASE; MOOD DISORDER; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; SEIZURE; SLEEP AROUSAL DISORDER; SLEEP DISORDER; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BLAST INJURIES; BRAIN INJURIES; HUMANS; MILITARY PERSONNEL; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; WAR;

EID: 70449127366     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854040903277289     Document Type: Review

References (134)

1. Agrawal, A., Timothy, J., Pandit, L., & Manju, M. (2006). Post-traumatic epilepsy: An overview. Clinical Neurology and Neurosurgery, 108(5), 433-439.
2. Alderfer, B. S., Arciniegas, D. B., & Silver, J. M. (2005). Treatment of depression following traumatic brain injury. Journal of Head Trauma Rehabilitation, 20(6), 544-562.
3. American Psychiatric Association (2006). American psychiatric association practice guidelines for the treatment of psychiatric disorders. Arlington, VA: American Psychiatric Publishing.
4. Arciniegas, D. B., Harris, S. N., & Brousseau, K. M. (2003). Psychosis following traumatic brain injury. International Review of Psychiatry, 15(4), 328-340.
5. Arciniegas, D. B., & Silver, J. M. (2006). Pharmacotherapy of posttraumatic cognitive impairments [review]. Behavioural Neurology, 17(1), 25-42.
6. Arnsten, A., & Li, B-M. (2005). Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biological Psychiatry, 57(11), 1377-1384.
7. Arnsten, A. F. T. (2007). Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": A rational bridge between geneticsand the symptoms of mental illness. Cerebral Cortex, 17(Suppl 1), 6-15.
8. Ashman, T., Cantor, J., Gordon, W., Spielman, L., Flanagan, S., Ginsberg, A., et al. (2009). A randomized controlled trial of sertraline for the treatment of depression in individuals with traumatic brain injury. General Hospital Psychiatry, 90(5), 733-740.
9. Ashman, T. A., Spielman, L. A., Hibbard, M. R., Silver, J. M., Chandna, T., & Gordon, W. A. (2004). Psychiatric challenges in the first 6 years after traumatic brain injury: Cross-sequential analyses of axis i disorders. Archives of Physical Medicine and Rehabilitation, 85(Suppl 2), S36-42.
10. Australian Centre for Posttraumatic Mental Health (2007). Austrailian guidelines for the treatment of adults with acute stress disorder and posttraumatic stress disorder. Melbourne, Victoria: ACPMH.
11. Bartzokis, G., Lu, P. H., Turner, J., Mintz, J., & Saunders, C. S. (2005). Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biological Psychiatry, 57(5), 474-479.
12. Belanger, H., Curtiss, G., Demery, J., Lobowitz, B., & Vanderploeg, R. (2005). Factors moderating neuropsychological outcomes following mild traumatic brain injury: A meta-analysis. Journal of the International Neuropsychological Society, 11, 215-227. (Pubitemid 40790614)
13. Belanger, H., Vanderploeg, R., Curtiss, G., & Warden, D. (2007). Recent neuroimaging techniques in mild traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 19(1), 5-20. (Pubitemid 46294440)
14. Bigler, E. (2008). Neuropsychology and clinical neuroscience of persistent post-concussive syndrome. Journal of the International Neuropsychological Society, 14, 1-22.
15. Bigler, E. D. (2007). Anterior and middle cranial fossa in traumatic brain injury: Relevant neuroanatomy and neuropathology in the study of neuropsychological outcome [review; 119 refs]. Neuropsychology, 21(5), 515-531.
16. Binder, L. M., & Rohling, M. L. (1996). Money matters: A meta-analytic review of the effects of financial incentives on recovery after closed-head injury [see comments]. American Journal of Psychiatry, 153(1), 7-10.
17. Bombardier, C., Fann, J., Temkin, N., Esselman, P., Pelzer, E., Keough, M., et al. (2006). Posttraumatic stress disorder symptoms during the first six months after traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 18(4), 501-508.
18. Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA, 283(14), 1837-1844.
19. Bremner, J. D. (2007). Functional neuroimaging in post-traumatic stress disorder. Expert Review of Neurotherapeutics, 7(4), 393-405.
20. Bryant, R., Moulds, M., Guthrie, R., & Nixon, R. (2003). Treating acute stress disorder following mild traumatic brain injury. American Journal of Psychiatry, 160(3), 585-587.
21. Bryant, R. A., & Harvey, A. G. (1998). Relationship between acute stress disorder and posttraumatic stress disorder following mild traumatic brain injury. American Journal of Psychiatry, 155(5), 625-629.
22. Bryant, R. A., & Harvey, A. G. (1999a). Postconcussive symptoms and posttraumatic stress disorder after mild traumatic brain injury. Journal of Nervous and Mental Disease, 187(5), 302-305.
23. Bryant, R. A., & Harvey, A. G. (1999b). The influence of traumatic brain injury on acute stress disorder and post-traumatic stress disorder following motor vehicle accidents. Brain Injury, 13(1), 15-22.
24. Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S., Churchill, L. E., & Davidson, J. R. (2001). Olanzapine in the treatment of post-traumatic stress disorder: A pilot study. International Clinical Psychopharmacology, 16(4), 197-203.
25. Carroll, L. J., Cassidy, J. D., Peloso, P. M., Borg, J., von Holst, H., Holm, L., et al. (2004). Prognosis for mild traumatic brain injury: Results of the WHO collaborating centre task force on mild traumatic brain injury. Journal of Rehabilitation Medicine, 43(Suppl), 84-105. (Pubitemid 38268224)
26. Cernak, I., Wang, Z., Jiang, J., Bian, X., & Savic, J. (2001). Ultrastructural and functional characteristics of blast injury-induced neurotrauma. Journal of Trauma, 50(4), 695-706. (Pubitemid 32336257)
27. Chamberlain, S. R., Muller, U., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006). Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology, 188(4), 397-407.
28. Cicerone, K., Dahlberg, C., Kalmar, K., Langenbahn, D. M., Malec, J., Bergquist, T. F., et al. (2000). Evidence-based cognitive rehabilitation: Recommendations for clinical practice. Archives of Physical Medicine and Rehabilitation, 81, 1596-1615.
29. Cicerone, K., Levin, H., Malec, J., Stuss, D., & Whyte, J. (2006). Cognitive rehabilitation interventions for executive function: Moving from bench to bedside in patients with traumatic brain injury. Journal of Cognitive Neuroscience, 18(7), 1212-1222.
30. Coffey, C. (2007). Disturbances of mood, emotion, and affect. In C. E. Coffey & J. M. Silver (Eds.), Guide to neuropsychiatric therapeurics. Philadelphia: Lippincott Williams & Wilkins.
31. Cosetti, M., & Lalwani, A. (in press). Dizziness, imbalance and vestibular dysfunction after traumatic brain injury. In J. Silver, T. McAllister, & S. Yudofsky (Eds.), Textbook of traumatic brain injury (2nd ed.). Washington, DC: Amercan Psychiatric Publishing.
32. Cramer, J., DeRue, K., Devinsky, O., Edrich, P., & Trimble, M. (2003). A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav, 4, 124-132.
33. Davidson, J. R., Brady, K., Mellman, T. A., Stein, M. B., & Pollack, M. H. (2007). The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. Journal of Clinical Psychopharmacology, 27(1), 85-88.
34. Davidson, J. R., Brady, K., Mellman, T. A., Stein, M. B., & Pollack, M. H. (2007). The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. Journal of Clinical Psychopharmacology, 27(1), 85-88.
35. Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006). Effects of d-cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369-375.
36. De Silva, M., Roberts, I., Perel, P., Edwards, P., Kenward, M., Fernandes, J., et al. (2009). Patient outcome after traumatic brain injury in high-, middle- and low-income countries: Analysis of data on 8927 patients in 46 countries. International Journal of Epidemiology, 38(2), 452-458.
37. Deb, S., Lyons, I., & Koutzoukis, C. (1998). Neuropsychiatric sequelae one year after a minor head injury. Journal of Neurology, Neurosurgery and Psychiatry, 65(6), 899-902.
38. Fann, J. R., Burington, B., Leonetti, A., Jaffe, K., Katon, W. J., & Thompson, R. S. (2004). Psychiatric illness following traumatic brain injury in an adult health maintenance organization population [see comment]. Archives of General Psychiatry, 61(1), 53-61.
39. Feldman, G. (2007). Cognitive and behavioral therapies for depression: Overview, new directions, and practical recommendations for dissemination. Psychiatric Clinics of North America, 30(1), 39-50.
40. Foa, E., Dancu, C., Zayfert, C., Mueser, K., & Descamps, M. (1997). Therapist guide: Brief cognitive behavior therapy for post-traumatic stress disorders in survivors of childhood sexual abuse. White River Junction, VT: National Center for Post-Traumatic Stress Disorder, Veterans Affairs Medical and Regional Office Center.
41. Foa, E., Keane, T., & Friedman, M. (2000). Effective treatments for PTSD: Practice guidelines from the international society for traumatic stress studies. New York: Guilford Press.
42. Friedman, M. J., & Davidson, J. R. T. (2007). Pharmacotherapy for PTSD. In M. J. Friedman, T. M. Keane, & P. A. Resick (Eds.), Handbook of PTSD (pp. 376-405). New York: Guilford Press.
43. Friedman, M. J., Marmar, C., Baker, D., Sikes, C., & Farfel, G. (2007). Randomized, double-blind comparison of sertraline and placebo for post-traumatic stress disorder in a department of veterans affairs setting. Journal of Clinical Psychiatry, 68, 711-720.
44. Galea, S., Ahern, J., Tracy, M., Hubbard, A., Cerda, M., Goldmann, E., et al. (2008). Longitudinal determinants of posttraumatic stress in a population-based cohort study. Epidemiology, 19, 47-54.
45. Gelpin, E., Bonne, O., Peri, T., Brandes, D., & Shalev, A. Y. (1996). Treatment of recent trauma survivors with benzodiazepines: A prospective study. Journal of Clinical Psychiatry, 57(9), 390-394. (Pubitemid 26321989)
46. Green, R., Colella, B., Hebert, D., Bayley, M., Kang, H., Till, C., et al. (2008). Prediction of return to productivity after severe traumatic brain injury: Investigations of optimal neuropsychological tests and timing of assessment. Archives of Physical Medicine and Rehabilitation, 89(12 Suppl), S51-60.
47. Greiffenstein, M. (2009). Clinical myths of forensic neuropsychology. The Clinical Neuropsychologist, 23, 286-296.
48. Grunze, H. (2008). The effectiveness of anticonvulsants in psychiatric disorders. Dialogues in Clinical Neuroscience, 10(1), 77-89.
49. Haltiner, A., Temkin, N., Winn, H., & Dikmen, S. (1996). The impact of posttraumatic seizures one year neuropsychological and psychological outcome after head injury. Journal of the International Neuropsychological Society, 2, 494-504.
50. Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Frueh, B. C., Huber, M. G., & Arana, G. W. (2003). Adjunctive risperidone treatment in post-traumatic stress disorder: A preliminary controlled trial of effects on comorbid psychotic symptoms. International Clinical Psychopharmacology, 18(1), 1-8.
51. Harvey, A., Brewin, C., Jones, C., & Kopelman, M. (2003). Coexistence of posttraumatic stress disorder and traumatic brain injury: Towards a resolution of the paradox. Journal of the International Neuropsychological Society, 9(4), 663-676.
52. Harvey, A. G., & Bryant, R. A. (1998a). Acute stress disorder after mild traumatic brain injury. Journal of Nervous and Mental Disease, 186(6), 333-337.
53. Harvey, A. G., & Bryant, R. A. (1998b). Predictors of acute stress following mild traumatic brain injury. Brain Injury, 12(2), 147-154.
54. Heresco-Levy, U., Kremer, I., Javitt, D. C., Goichman, R., Reshef, A., Blanaru, M., et al. (2002). Pilot-controlled trial of d-cycloserine for the treatment of post-traumatic stress disorder. International Journal of Neuropsychopharmacology, 5(4), 301-307.
55. Hertzberg, M. A., Butterfield, M. I., Feldman, M. E., Beckham, J. C., Sutherland, S. M., Connor, K. M., et al. (1999). A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry, 45(9), 1226-1229.
56. Hibbard, M. R., Uysal, S., Kepler, K., Bogdany, J., & Silver, J. (1998). Axis I psychopathology in individuals with traumatic brain injury. Journal of Head Trauma Rehabilitation, 13(4), 24-39. (Pubitemid 28419870)
57. Hoge, C., Castro, C., Messer, S., McGurk, D., Cotting, D., & Koffman, R. (2004). Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine, 351, 13-22. (Pubitemid 38857243)
58. Hoge, C., Goldberg, H., & Castro, C. (2009). Care of war veterans with mild traumatic brain injury - flawed perspectives. New England Journal of Medicine, 360(16), 1588-1591.
59. Hoge, C., McGurk, D., Thomas, J., Cox, A., Engel, C., & Castro, C. (2008). Mild traumatic brain injury in U.S. Soldiers returning from Iraq. New England Journal of Medicine, 358(5), 453-463.
60. Hollon, S., Jarrett, R., Nierenberg, A., Thase, M., Trivedi, M., & Rush, A. (2005). Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment? Journal of Clinical Psychiatry, 66(4), 455-468.
61. Institute of Medicine (2008). Treatment of posttraumatic stress disorder: An assessment of the evidence. Washington, DC: The National Academies Press.
62. Institute of Medicine (2009). Gulf war and health, volume 7: Long-term consequences of traumatic brain injury. Washington, DC: The National Academies Press.
63. Jordan, B. D. (2007). Genetic influences on outcome following traumatic brain injury. Neurochemical Research, 32, 905-915.
64. Kapoor, N., & Ciuffreda, K. (in press). Vision problems. In J. Silver, T. McAllister, & S. Yudofsky (Eds.), Textbook of traumatic brain injury (2nd ed.). Washington, DC: Amercan Psychiatric Publishing.
65. Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the national comorbidity survey. Archives of General Psychiatry, 52, 1048-1060.
66. Konovalov, S., Muralee, S., & Tampi, R. (2008). Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: A literature review. International Psychogeriatrics, 20(2), 293-308.
67. Kraus, J., Schaffer, K., Ayers, K., Stenehjem, J., Shen, H., & Afifi, A. A. (2005). Physical complaints, medical service use, and social and employment changes following mild traumatic brain injury: A 6-month longitudinal study. Journal of Head Trauma Rehabilitation, 20(3), 239-256.
68. Lee, H. B., Lyketsos, C. G., & Rao, V. (2003). Pharmacological management of the psychiatric aspects of traumatic brain injury. International Review of Psychiatry, 15(4), 359-370. (Pubitemid 37421588)
69. Levin, H. S., Mattis, S., Ruff, R. M., Eisenberg, H. M., Marshall, L. F., Tabaddor, K., et al. (1987). Neurobehavioral outcome following minor head injury: A three-center study. Journal of Neurosurgery, 66(2), 234-243.
70. Martenyi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002). Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry, 63(3), 199-206.
71. Massagli, T., Fann, J., Burington, B., Jaffe, K., Katon, W., & Thompson, R. (2004). Psychiatric illness after mild traumatic brain injury in children. Archives of Physical Medicine and Rehabilitation, 85, 1428-1434.
72. Mayorga, M. A. (1997). The pathology of primary blast overpressure injury. Toxicology, 121(1), 17-28.
73. McAllister, T. (2005). Mild brain injury and postconcussive symptoms. In J. Silver, S. Yudofsky, & T. McAllister (Eds.), Textbook of traumatic brain injury (2nd ed., pp. 279-308). Arlington, VA: American Psychiatric Press, Inc.
74. McAllister, T. (2007). Neuropsychiatric aspects of TBI. In N. Zasler, D. Katz, & R. Zafonte (Eds.), Brain injury medicine: Principles and practice (pp. 835-864). New York: Demos Medical Publishing, Inc.
75. McAllister, T. (2008). Neurobehavioral sequelae of traumatic brain injury: Evaluation and treatment. World Psychiatry, 7, 3-10.
76. McAllister, T., & Ferrell, R. (2002). Evaluation and treatment of psychosis after traumatic brian injury. NeuroRehabilitation, 17, 357-368.
77. McAllister, T. W., & Arciniegas, D. (2002). Evaluation and treatment of postconcussive symptoms. NeuroRehabilitation, 17(4), 265-283.
78. McAllister, T. W., Flashman, L. A., Sparling, M. B., & Saykin, A. J. (2004). Working memory deficits after traumatic brain injury: Catecholaminergic mechanisms and prospects for treatment - a review. Brain Injury, 18(4), 331-350.
79. McCrea, M., Iverson, G., McAllister, T., Hammeke, T., Powell, M., Barr, W., et al. (2009). An integrated review of recovery after mild traumatic brain injury (MTBI): Implications for clinical management. The Clinical Neuropsychologist, 23(8), 1368-1390.
80. McDougle, C. J., Stigler, K. A., Erickson, C. A., & Posey, D. J. (2008). Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. Journal of Clinical Psychiatry, 69(Suppl 4), 15-20.
81. Mellman, T. A., Bustamante, V., David, D., & Fins, A. I. (2002). Hypnotic medication in the aftermath of trauma. Journal of Clinical Psychiatry, 63(12), 1183-1184.
82. Monnelly, E. P., Ciraulo, D. A., Knapp, C., & Keane, T. (2003). Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 23(2), 193-196.
83. Mooney, G., & Speed, J. (2001). The association between mild traumatic brain injury and psychiatric conditions. Brain Injury, 15, 865-877.
84. Mooney, G., Speed, J., & Sheppard, S. (2005). Factors related to recovery after mild traumatic brain injury. Brain Injury, 19(12), 975-987.
85. Mula, M., Monaco, F., & Trimble, M. (2004). Use of psychotropic drugs in patients with epilepsy: Interactions and seizure risk. Expert Review of Neurotherapeutics, 4(6), 953-964.
86. Mula, M., Trimble, M., Yuen, A., Liu, R., & Sander, J. (2003). Psychiatric adverse events during levetiracetam therapy. Neurology, 61, 704-706. (Pubitemid 37082613)
87. National Institute for Health and Clinical Excellence (2005). Post-traumatic stress disorder (PTSD): The management of ptsd in adults and children in primary and secondary care. London: National Institute for Clinical Excellence.
88. Neumeister, A., Wood, S., Bonne, O., Nugent, A. C., Luckenbaugh, D. A., Young, T., et al. (2005). Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biological Psychiatry, 57(8), 935-937.
89. Neylan, T. C., Lenoci, M., Franklin, K. W., Metzler, T. J., Henn-Haase, C., Hierholzer, R. W., et al. (2006). No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. American Journal of Psychiatry, 163, 2186-2188.
90. Norberg, M., Krystal, J., & Tolin, D. (2008). A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118-1126.
91. Okie, S. (2005). Traumatic brain injury in the war zone [see comment]. New England Journal of Medicine, 352(20), 2043-2047.
92. Ommaya, A., Ommaya, A., Dannenberg, A., & Salazar, A. (1996). Causation, incidence, and costs of traumatic brain injury in the U.S. Military medical system. Journal of Trauma, 40(2), 211-217. (Pubitemid 26064417)
93. Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., et al. (2006). Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. International Clinical Psychopharmacology, 21(5), 275-280.
94. Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004). Combined pharmacotherapy and psychological treatment for depression: A systematic review. Archives of General Psychiatry, 61, 714-719.
95. Passmore, M., Gardner, D., Polak, Y., & Rabheru, K. (2008). Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs and Aging, 25(5), 381-398.
96. Perel, P., Edwards, P., Wentz, R., & Roberts, I. (2006). Systematic review of prognostic models in traumatic brain injury. BMC Medical Informatics & Decision Making, 6, 38.
97. Pitman, R., Sanders, K., Zusman, R., Healy, A., Cheema, F., Lasko, N., et al. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry, 51(2), 189-192.
98. Pitman, R. K., & Delahanty, D. L. (2005). Conceptually driven pharmacologic approaches to acute trauma. CNS Spectrums, 10(2), 99-106.
99. Pitman, R. K., Gilbertson, M. W., Gurvits, T. V., May, F. S., Lasko, N. B., Metzger, L. J., et al. (2006). Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Annals of the New York Academy of Sciences, 1071, 242-254.
100. Raskind, M., Peskind, E., Hoff, D., Hart, K., Holmes, H., Warren, D., et al. (2007). A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder [see comment]. Biological Psychiatry, 61(8), 928-934.
101. Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radont, A., Thompson, C., et al. (1996). Prazosin reduces nightmares and other PTSD symptoms in combat veterans: A placebo-controlled study. American Journal of Psychiatry, 153(11), 1503.
102. Ray, W., Chung, C., Murray, K., Hall, K., & Stein, C. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360, 225-235.
103. Reich, D. B., Winternitz, S., Hennen, J., Watts, T., & Stanculescu, C. (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. Journal of Clinical Psychiatry, 65(12), 1601-1606.
104. Risbrough, V., & Stein, M. (2006). Role of corticotropin releasing factor in anxiety disorders: A translational research perspective. Hormones and Behavior, 50(4), 550-561.
105. Rogawski, M. A., & Loscher, W. (2004). The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Medicine, 10(7), 685-692.
106. Rutherford, W., Merrett, J., & McDonald, J. (1979). Symptoms at one year following concussion from minor head injuries. Injury Prevention, 10(3), 225-230.
107. Sbordone, R. J., & Liter, J. C. (1995). Mild traumatic brain injury does not produce posttraumatic stress disorder. Brain Injury, 9(4), 405-412.
108. Schneiderman, A., Braver, E., & Kang, H. (2008). Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: Persistent postconcussive symptoms and posttraumatic stress disorder. American Journal of Epidemiology, 167, 1446-1452.
109. Southwick, S., Davis, L., Aikins, D., Rasmusson, A., Barron, J., & Morgan, C. I. (2007). Neurobiological alterations associated with PTSD. In M. J. Friedman, T. M. Keane, & P. A. Resick (Eds.), Handbook of PTSD. New York: Guilford Publications.
110. Stein, M., & McAllister, T. (2009). A beating of minds: Exploring the convergence of posttraumatic stress disorder and mild traumatic brain injury. American Journal of Psychiatry, 166, 768-776.
111. Stein, M. B., Kline, N. A., & Matloff, J. L. (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study. American Journal of Psychiatry, 159(10), 1777-1779.
112. Steyerberg, E., Mushkudiani, N., Perel, P., Butcher, I., Lu, J., McHugh, G., et al. (2008). Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Med, 5(8), e168.
113. Strawn, J., & Geracioti, T. J. (2008). Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depression and Anxiety, 25(3), 260-271.
114. Sumpter, R., & McMillan, T. (2006). Errors in self-report of post-traumatic stress disorder after severe traumatic brain injury. Brain Injury, 20(1), 93-99.
115. Tanielian, T., & Jaycox, L. H. (Eds.). (2008). Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery. Washington, DC: RAND Corporation.
116. Taylor, F., Martin, P., Thompson, C., Williams, J., Mellman, T., Gross, C., et al. (2008). Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biological Psychiatry, 63(6), 629-632.
117. Taylor, F. B., Lowe, K., Thompson, C., McFall, M. M., Peskind, E. R., Kanter, E. D., et al. (2006). Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biological Psychiatry, 59(7), 577-581.
118. Teasell, R., Bayona, N., Lippert, C., Villamere, J., & Hellings, C. (2007). Post-traumatic seizure disorder following acquired brain injury. Brain Injury, 21(2), 201-214. (Pubitemid 46443632)
119. Tucker, P., Trautman, R. P., Wyatt, D. B., Thompson, J., Wu, S. C., Capece, J. A., et al. (2007). Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 68(2), 201-206.
120. Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo controlled, flexible dosage trial. Journal of Clinical Psychiatry, 62(11), 860-868.
121. Vaishnavi, S., Makley, M., & Rao, V. (in press). Sleep disturbances and fatigue. In J. Silver, T. McAllister, & S. Yudofsky (Eds.), Textbook of traumatic brain injury (2nd ed.). Washington, DC: Amercan Psychiatric Publishing.
122. van der Kolk, B. A., Spinazzola, J., Blaustein, M. E., Hopper, J. W., Hopper, E. K., Korn, D. L., et al. (2007). A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: Treatment effects and long-term maintenance. Journal of Clinical Psychiatry, 68(1), 37-46.
123. van Reekum, R., Cohen, T., & Wong, J. (2000). Can traumatic brain injury cause psychiatric disorders? Journal of Neuropsychiatry and Clinical Neuroscience, 12, 316-327.
124. van Stegeren, A. H. (2008). The role of the noradrenergic system in emotional memory. Acta Psychologica, 127(3), 532-541.
125. Vasterling, J., Proctor, S., Amoroso, P., Kane, R., Heeren, T., & White, R. (2006). Neuropsychological outcomes of army personnel following deployment to the Iraq war. JAMA, 296(5), 519-529.
126. Vasterling, J. J., Duke, L. M., Brailey, K., Constans, J. I., Allain, A. N.Jr., & Sutker, P. B. (2002). Attention, learning, and memory performances and intellectual resources in vietnam veterans: PTSD and no disorder comparisons. Neuropsychology, 16(1), 5-14.
127. Veterans Health Administration/Department of Defense (2004). VA/DOD clinical practice guideline for the management of post-traumatic stress. Washington, DC: Department of Veterans Affairs.
128. Warden, D. (2006). Military TBI during the Iraq and Afghanistan wars. Journal of Head Trauma Rehabilitation, 21(5), 398-402.
129. Warden, D. C., Labbate, L. A., Salazar, A. M., Nelson, R., Sheley, E., Staudenmeier, R., et al. (1997). Posttraumatic stress disorder in patients with traumatic brain injury and amnestic for the event. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 18-22.
130. Warden, D. L., Gordon, B., McAllister, T. W., Silver, J. M., Barth, J. T., et al. (2006). Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. Journal of Neurotrauma, 23(10), 1468-1501.
131. Weisler, R., Cutler, A., Ballenger, J., Post, R., & Ketter, T. (2006). The use of antiepileptic drugs in bipolar disorders: A review based on evidence from controlled trials. CNS Spectrums, 11(10), 788-799.
132. Willemse-van Son, A., Ribbers, G., Verhagen, A., & Stam, H. (2007). Prognostic factors of long-term functioning and productivity after traumatic brain injury: A systematic review of prospective cohort studies. Clinical Rehabilitation, 21(11), 1024-1037.
133. Yamamoto, S., Morinobu, S., Fuchikami, M., Kurata, A., Kozuru, T., & Yamawaki, S. (2008). Effects of single prolonged stress and d-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology, 33(9), 2108-2116.
134. Zohar, J., Amital, D. C., Miodownik, M. K., Bleich, A., Lane, R. M., & Austin, C. (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 22(2), 190-195.